Erdal CEYLAN, Ahmet Çağkan İNKAYA, Serhat ÜNAL, Ayşegül KOÇ

Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital

Background/aim: Widespread use of antiretroviral treatment (ART) has led to decrease in the incidence of HIV/AIDS-related mortality.Besides the availability of ART, medication adherence is essential for treatment success. There is a scarcity of data reported fromTurkey regarding ART adherence among people living with HIV/AIDS (PLWHA). Therefore, this study was undertaken to determinemedication adherence and related factors among PLWHA in Turkey.Materials and methods: The sample consisted of 158 PLWHA, who were being followed up at Infectious Diseases Outpatient Clinic ofHacettepe University Hospital. Data were collected using an individual questionnaire and the Turkish version of the Morisky MedicationAdherence Scale.Results: The median patient age was 38 years, 80.4% were male, and 51.3% were married. The median duration of both HIV infectionand ART was 3 years. Sixty-one percent used two drug regimens. Sixty-one percent were highly adherent to ART while 37.9% weremoderately adherent. The absence/presence of social support resources, disease duration, ART duration, and being informed about theART regimen were statistically associated with medication adherence.Conclusion: Our results suggest that medication adherence is excellent among Turkish PLWHA. Interventions, including effectivesocial support, and continuous counseling about ART, might further boost the adherence of PLWHA.

PDF

___

1. Foresto JS, Melo ES, Costa CRB, Antonini M, Gir E, Reis RK. Adherence to antiretroviral therapy by people living with HIV/ AIDS in a municipality of São Paulo. Rev Gaúcha Enferm 2017; 38: e63158.
2. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Bulaşıcı Hastalıklar Daire Başkanlığı İstatiksel Verileri. Ankara; 2016.
3. Gökengin D, Doroudi F, Tohme J, Collins B, Madani N. HIV/ AIDS: trends in the Middle East and North Africa region. Int J Infect Dis 2016; 44: 66-73.
4. Cihlar T, Fordyce M. Current status and prospects of HIV treatment. Curr Opin Virol 2016; 18: 50-56.
5. Wasti SP, Simkhada P, Randall J, Freeman JV, Van Teijlingen E. Barriers to and facilitators of antiretroviral therapy adherence in Nepal: a qualitative study. J Health Popul Nutr 2012; 30: 410- 419.
6. Kumarasamy N, Patel A, Pujari S. Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to? Indian J Med Res 2011; 134: 787-800.
7. Atuyambe L, Neema S, Otolok-Tanga E, Wamuyu-Maina G, Kasasa S, Wabwire-Mangen, F. The effects of enhanced access to antiretroviral therapy: A qualitative study of community perceptions in Kampala City, Uganda. Afr Health Sci 2008; 8: 13-19.
8. Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV positive patients: a qualitative study from Ethiopia. PloS One 2014; 9: e97353.
9. Schaecher KL. The importance of treatment adherence in HIV. Am J Manag Care 2013; 19: S231-S237.
10. Chaiyachati KH, Ogbuoji O, Price M, Suthar AB, Negussie EK, Bärnighausen T. Interventions to improve adherence to antiretroviral therapy: a rapid systematic review. AIDS 2014; 28: S187-S204.
11. Willie TC, Overstreet NM, Sullivan TP, Sikkema KJ, Hansen NB. Barriers to HIV medication adherence: Examining distinct anxiety and depression symptoms among women living with HIV who experienced childhood sexual abuse. Behav Med 2016; 42: 120-127.
12. Ceylan E, Koç A. HIV(+)/AIDS hastalarında antiretroviral tedaviye uyumun önemi (Literatür çalışması). JinekolojiObstetrik ve Neonatoloji Tıp Dergisi 2017; 14: 74-81 (in Turkish).
13. Günthard HF, Saag MS, Benson CA, Del Rio C, Eron JJ, Gallant JE, Mugavero MJ, Sax PE, Thompson MA et. al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society– USA panel. Jama 2016; 316: 191-210.
14. Chkhartishvili N, Abutidze A, Dvali N, Kempker R, Tsertsvadze T. Long-term adherence to antiretroviral therapy in Georgia. TCM-GMJ 2017; 2: 4-9.
15. Moradi A, Alavi SM, Fahimfar N, Haghighizadeh MH, Mirzaei B. Study of determinants of adherence to antiretroviral treatment among HIV patients covered by Ahwaz Jundishapur University of Medical Sciences. Int J Med Res Health Sci 2016; 5: 477-484.
16. Amirkhanian YA, Kelly JA, DiFranceisco WJ, Kuznetsova AV, Tarima SS, Yakovlev AA, Musatov VB. Predictors of HIV care engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg, Russia. AIDS Behav 2018; 22: 791-799.
17. Gavriilidou M. What role do psychosocial factors play in influencing HIV positive peoples’ compliance with medical treatment? PhD, Manchester Metropolitan University, Manchester, England, 2013.
18. Akıncı F, Öz F. HIV/AIDS’li hastaların tedaviye uyumunu etkileyen psikososyal faktörler. Türk HIV/AIDS Dergisi 2003; 6 (article in Turkish).
19. Hansana V, Sanchaisuriya P, Durham J, Sychareun V, Chaleunvong K, Boonyaleepun S, Schelp FP. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): A cross-sectional survey to measure in Lao PDR. BMC Public Health 2013; 13: 617.
20. Tran BX, Nguyen LT, Nguyen NH, Hoang QV, Hwang J. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action 2013; 6: 19570.
21. Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr J Public Health 2008; 5: 74- 78.
22. Waite KR, Paasche-Orlow M, Rintamaki LS, Davis TC, Wolf MS. Literacy, social stigma, and HIV medication adherence. J Gen Intern Med 2008; 23: 1367-1372.
23. Negash T, Ehlers V. Personal factors influencing patients’ adherence to ART in Addis Ababa, Ethiopia. J Assoc Nurses AIDS Care 2013; 24: 530-538.
24. Kalichman SC, Grebler T. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosom Med 2010; 72: 810-816.
25. Kibicho JW, Owczarzak J. Pharmacists’ perspectives on promoting medication adherence among patients with HIV. J Am Pharm Assoc 2011; 51: 746-755.
26. Sosyal Sigortalar ve Genel Sağlık Sigortası Kanunu (2006, 31 Mayıs). Resmi Gazete, (Kanun No. 5510) (in Turkish).
27. Sosyal Güvenlik Kurumu Sağlık Uygulama Tebliği (2013, 24 Mart). Resmi Gazete (Sayı: 28597) (in Turkish).
28. Chandwani S, Koenig LJ, Sill AM, Abramowitz S, Conner LC, D’Angelo L. Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV. J Adolesc Health 2012; 51: 242-251.
29. Genberg BL, Lee Y, Rogers WH, Wilson IB. Four types of barriers to adherence of antiretroviral therapy are associated with decreased adherence over time. AIDS Behav 2015; 19: 85- 92.
30. Vural B, Acar TÖ, Topsever P, Filiz TM. Reliability and validity of Turkish version of Modified Morisky Scale. Turk Fam Physician 2012; 3: 17-20.
31. Pruitt Z. The determinants of antiretroviral therapy adherence and the relationship of healthcare expenditures to adherence among Florida Medicaid-insured patients diagnosed with HIV or AIDS. PhD, University of South Florida, USA, 2013.
32. Letta S, Demissie A, Oljira L, Dessie Y. Factors associated with adherence to antiretroviral therapy (ART) among adult people living with HIV and attending their clinical care, Eastern Ethiopia. BMC Int Health Hum Rights 2015; 15: 33.
33. Oku AO, Owoaje ET, Ige OK Oyo-ita A. Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria. BMC Infect Dis 2013; 13: 401.
34. Intasan J, Bunupuradah T, Vonthanak S, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Apornpong T et al. Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial. AIDS Patient Care STDs 2014; 28: 296-302.
35. Morrison SD, Rashidi V, Sarnquist C, Banushi VH, Hole MK, Barbhaiya NJ, Gashi VH, Osterberg L, Maldonado Y, Harxhi A. Antiretroviral therapy adherence and predictors to adherence in Albania: a cross-sectional study. J Infect Dev Ctries 2014; 8: 853-862.
36. Poles G, Li M, Siril H, Mhalu A, Hawkins C, Kaaya S, Aris E, Chalamilla G, Hirschhorn LR. Factors associated with different patterns of nonadherence to HIV care in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care 2014; 13: 78-84.
37. Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group. Factors associated with non-adherence to longterm highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother 2009; 64: 599-606.
38. Tabatabai J, Namakhoma I, Tweya H, Phiri S, Schnitzler P, Neuhann F. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy – A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi. Glob Health Action 2014; 7: 24795.
39. Ross AJ, Aung M, Campbell L, Ogunbanjo GA. Factors that positively influence adherence to antiretroviral therapy by HIV and/or AIDS patients and their caregivers. Afr J Prim Health Care Fam Med 2011; 3: 196-200.
40. Sekoni AO, Obidike OR. Balogun MR. Stigma, medication adherence and coping mechanism among people living with HIV attending General Hospital, Lagos Island, Nigeria. Afr J Prim Health Care Fam Med 2012; 4: 417-426.
41. Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care 2011; 23: 1246-1253.
42. Sax PE, Meyers JL, Mugavero M, Davis KL. Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States. PLoS One 2012; 7: e31591.
43. Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, Mounzer K, Samuel R, Metlay JP, Yehia BR. Mapping patientidentified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen’s behavioral model. AIDS Care 2015; 27: 817-828.
44. Liu AY, Hessol NA, Vittinghoff E, Amico KR, Kroboth E, Fuchs J, Irvin R, Sineath RC, Sanchez T, Sullivan PS et al. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care STDs 2014; 28: 622-627.
45. MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav 2013; 17: 86-93.
46. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004; 19: 1096-1103.
47. Demirkıran F, Terakye G. Depresif hastaların ilaç tedavisine uyumları ve destekleyici hemşirelik uygulamalarının uyum düzeyine etkisi. Kriz Dergisi 1998; 9: 29-39 (article in Turkish).
48. Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med 1999; 14: 267-273.
49. Monreal MT, da Cunha RV, Trinca LA. Compliance to antiretroviral medication as reported by AIDS patients assisted at the University Hospital of the Federal University of Mato Grosso do Sul. Braz J Infect Dis 2002; 6: 8-14.
50. Yeap AD, Hamilton R, Charalambous S, Dwadwa T, Churchyard GJ, Geissler PW, Grant AD. Factors influencing uptake of HIV care and treatment among children in South Africa – a qualitative study of caregivers and clinic staff. AIDS Care 2010; 22: 1101-1107.
51. Joshi B, Chauhan S, Pasi A, Kulkarni R, Sunil N, Bachani D, Mankeshwar R, ART Adherence Study Group. Level of suboptimal adherence to first line antiretroviral treatment & its determinants among HIV positive people in India. Indian J Med Res 2014; 140: 84-95.